Search research articles
Contact Us
Filters
Showing results (61-70 of 563) with videos related to
Page
of 57
Sort By:
Journal of Medicinal Chemistry
|
October 1, 1985
Resolution of aristeromycin enantiomers
P Herdewijn, J Balzarini, E De Clercq, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1991
Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins
M Hosoya, J Balzarini, S Shigeta, et al.
International Journal of Cancer
|
March 15, 1986
Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)
J Balzarini, H Mitsuya, E De Clercq, et al.
Biochemical and Biophysical Research Communications
|
April 14, 1986
Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus
J Balzarini, H Mitsuya, E De Clercq, et al.
FEBS Letters
|
June 3, 1985
Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds
J Balzarini, E de Clercq, D Ayusawa, et al.
Nucleic Acids Symposium Series
|
January 1, 1986
Differential inhibitory effects of Evans blue on various DNA polymerases
H Nakane, J Balzarini, E De Clercq, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
June 19, 2014
The pyrimidine nucleoside phosphorylase of Mycoplasma hyorhinis and how it may affect nucleoside-based therapy
J Vande Voorde, S Liekens, F Gago, et al.
Journal of Medicinal Chemistry
|
May 1, 1985
Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines
P Herdewijn, E De Clercq, J Balzarini, et al.
Biochimica Et Biophysica Acta
|
April 29, 1998
Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA)
J Balzarini, S Hatse, L Naesens, et al.
Journal of Medicinal Chemistry
|
May 23, 1998
cycloSal-2',3'-dideoxy-2',3'-didehydrothymidine monophosphate (cycloSal-d4TMP): synthesis and antiviral evaluation of a new d4TMP delivery system
C Meier, M Lorey, E De Clercq, et al.
Page
of 57
Search research articles
Search
Showing results (61-70 of 563) with videos related to
Sort By:
Page
of 57
Journal of Medicinal Chemistry
|
October 1, 1985
Resolution of aristeromycin enantiomers
P Herdewijn, J Balzarini, E De Clercq, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1991
Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins
M Hosoya, J Balzarini, S Shigeta, et al.
International Journal of Cancer
|
March 15, 1986
Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)
J Balzarini, H Mitsuya, E De Clercq, et al.
Biochemical and Biophysical Research Communications
|
April 14, 1986
Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus
J Balzarini, H Mitsuya, E De Clercq, et al.
FEBS Letters
|
June 3, 1985
Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds
J Balzarini, E de Clercq, D Ayusawa, et al.
Nucleic Acids Symposium Series
|
January 1, 1986
Differential inhibitory effects of Evans blue on various DNA polymerases
H Nakane, J Balzarini, E De Clercq, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
June 19, 2014
The pyrimidine nucleoside phosphorylase of Mycoplasma hyorhinis and how it may affect nucleoside-based therapy
J Vande Voorde, S Liekens, F Gago, et al.
Journal of Medicinal Chemistry
|
May 1, 1985
Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines
P Herdewijn, E De Clercq, J Balzarini, et al.
Biochimica Et Biophysica Acta
|
April 29, 1998
Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA)
J Balzarini, S Hatse, L Naesens, et al.
Journal of Medicinal Chemistry
|
May 23, 1998
cycloSal-2',3'-dideoxy-2',3'-didehydrothymidine monophosphate (cycloSal-d4TMP): synthesis and antiviral evaluation of a new d4TMP delivery system
C Meier, M Lorey, E De Clercq, et al.
Page
of 57